In this study, we engineered a BiKE equipped with a single-domain antibody against CD16, a stimulatory molecule on NK cells, and a single-chain antibody against IL13Rα2, an antigen overexpressed in 60% of glioblastoma tumors [38,39]. This evidence concerns the gene IL13RA2 and glioblastoma.